News Home

Do Analysts Agree Wednesday on Aadi Bioscience Inc (AADI) Stock's Target Price?

Wednesday, January 19, 2022 03:00 PM | InvestorsObserver Analysts
Do Analysts Agree Wednesday on Aadi Bioscience Inc (AADI) Stock's Target Price?

Wall Street is positive on Aadi Bioscience Inc (AADI). On average, analysts give the stock a Strong Buy rating. The average price target is $50, which means analysts expect the stock to increase by 141.20% over the next twelve months. That average ranking earns the stock an Analyst Rating of 74, which is better than 74% of stocks based on data compiled by InvestorsObserver.

Overall Score - 5
Wall Street analysts are rating AADI a Strong Buy today. Find out what this means to you and get the rest of the rankings on AADI!

Why are Analyst Ratings Important?

A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement. InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.

What's Happening With Aadi Bioscience Inc Stock Today?

Aadi Bioscience Inc (AADI) stock is trading at $20.73 as of 2:57 PM on Wednesday, Jan 19, a loss of -$1.19, or -5.43% from the previous closing price of $21.92. The stock has traded between $20.24 and $21.90 so far today. Volume today is 237,299 compared to average volume of 200,389. Click Here to get the full Stock Report for Aadi Bioscience Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App